12.3 The Irish National Immunisation Schedule, NIAC Guidelines, and Vaccine Hesitancy

Key Takeaways

  • The two-month visit includes 6-in-1, PCV, MenB and oral rotavirus vaccine in both Irish birth cohorts.

  • Children born on or after 1 October 2024 get no MenC at six months. They get varicella at 12 months and a fourth 6-in-1, MenC and PCV at 13 months.

  • Irish rotavirus catch-up depends on exact age and prior doses. For a two-dose late Rotarix course, use a first dose before seven months and the final dose before eight months, at least four weeks apart.

  • At the 2- and 4-month MenB visits, give the first prophylactic liquid paracetamol dose at or soon after vaccination and space the next two doses 4–6 hours apart.

  • Egg anaphylaxis alone allows routine MMR vaccination. Active immunosuppressive chemotherapy requires deferring MMR and varicella and arranging specialist-led catch-up.

Last updated: November 2026

Who sets the schedule?

The National Immunisation Advisory Committee (NIAC) develops immunisation guidelines and advises Ireland's Minister for Health. It has been hosted by the Health Information and Quality Authority (HIQA) since 31 March 2025. The Health Service Executive (HSE) provides the routine childhood programme. Use the current HSE schedule for visit timing and the relevant NIAC chapter for contraindications or catch-up.

Start with the date of birth and vaccine record

A child aged 13 months who has received all scheduled doses has different needs from a child of the same age who missed several visits. Confirm the exact date of birth and document which products and doses were given and when. Determine what would have been due on the routine schedule, then check current catch-up recommendations for any gaps, including age limits and minimum intervals.

Primary childhood vaccination from 2 to 13 months

The primary schedule is delivered in general practice. HSE Circular NCO-42-2024 introduced a revised programme for children born on or after 1 October 2024. The early visits stayed the same. The changes affect meningococcal C (MenC) at 6 and 13 months, chickenpox at 12 months, and the fourth 6-in-1 dose at 13 months.

6-in-1 protects against diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (Hib) and hepatitis B. PCV is pneumococcal conjugate vaccine. MenB and MenC protect against different meningococcal groups. MMR is the measles, mumps and rubella vaccine. Rotavirus vaccine is given orally.

Rotavirus timing for a late presentation

The routine Irish oral Rotarix schedule is at 2 and 4 months. NIAC Chapter 19 advises a first dose ideally before 16 weeks. For a late start under the Irish recommendations, two Rotarix doses can be scheduled if the first is given before 7 months and the final dose before 8 months, with at least 4 weeks between doses. The EMA product information licenses completion by 24 weeks. When the Irish catch-up plan extends beyond the licensed age, follow the national/local process for that use. Check the exact age and records before scheduling the next dose. A history of intussusception, a congenital bowel abnormality predisposing to it or severe combined immunodeficiency requires withholding the vaccine.

Paracetamol after MenB in early infancy

The HSE MenB guidance recommends liquid paracetamol at the 2- and 4-month visits when MenB is given. Give the first dose at or just after vaccination, then the second 4–6 hours later and the third 4–6 hours after the second. For the usual 120 mg/5 mL liquid, 2.5 mL is 60 mg. Confirm the individual dose with the vaccinator, including for a small or preterm infant. Routine preventive dosing is for these two visits.

VisitBorn on or after 1 October 2024Historical routine schedule for births before 1 October 2024
2 months6-in-1, PCV, MenB and oral rotavirusSame
4 months6-in-1, MenB and oral rotavirusSame
6 months6-in-1 and PCV6-in-1, PCV and MenC
12 monthsMMR, MenB and varicellaMMR and MenB
13 monthsFourth 6-in-1, MenC and PCVCombined Hib/MenC and PCV

The historical column describes the former scheduled products. The HSE says the combined Hib/MenC product will no longer be available. For a child from the earlier cohort who missed that visit, use current catch-up guidance and consult the local immunisation team if needed.

For example, two children were born on 30 September and 1 October 2024. At their routine 12-month visits, the first was scheduled for MMR and MenB, and the second was scheduled for those two vaccines plus varicella. At 13 months the second child was scheduled for the fourth 6-in-1, MenC and PCV. Check each child's record before administering any dose.

School and targeted programmes

Junior infants and first year of post-primary school

In junior infants, usually at 4–5 years of age, children are offered a 4-in-1 booster against diphtheria, tetanus, pertussis and polio. The earlier cohort receives its second MMR dose. Under the newer birth-cohort schedule the combined MMRV vaccine provides the second measles, mumps and rubella dose and the second varicella dose. See the HSE cohort schedule.

First-year post-primary pupils are offered human papillomavirus (HPV), meningococcal ACWY and Tdap vaccines. The routine school HPV course for immunocompetent pupils is one dose. Some immunocompromised pupils need three doses. Confirm the plan with their specialist and the school vaccination team. See HSE HPV guidance.

Additional protection when indicated

The HSE selective BCG programme offers tuberculosis vaccination to eligible infants at higher risk. Check the programme criteria and newborn screening requirements before vaccination.

The HSE winter programme offers nasal influenza vaccine to eligible children aged 2–17 years. Check the current season's eligibility and use the appropriate formulation where a child cannot receive the live nasal vaccine. The 2026–27 infant RSV programme offers eligible infants nirsevimab, a preventive antibody that provides passive protection.

Decide whether to vaccinate, defer or seek advice

FindingClinical decision
Anaphylaxis after a previous dose or to a constituent of the planned vaccineWithhold the implicated vaccine and obtain appropriate specialist advice.
Egg allergy, including anaphylaxis after eating eggGive routine MMR if otherwise eligible. Egg allergy alone does not require skin testing or a special setting for MMR.
Active immunosuppressive chemotherapyWithhold MMR and varicella. Coordinate future vaccination with the treating team according to the vaccine and the patient's immune recovery.
Minor illness or stable neurological diseaseUsually proceed. Defer during significant acute illness as indicated by clinical and vaccine-specific guidance.
PrematurityUse chronological age for routine vaccines. Check vaccine-specific precautions and the neonatal monitoring plan for infants still in hospital.
Recent blood products or immunoglobulinCheck the product, dose and timing before giving MMR or varicella. Passively acquired antibody may interfere with vaccine response.
Pregnancy or severe immunosuppressionCheck contraindications to each live vaccine. MMR and varicella are contraindicated during pregnancy. Seek specialist advice if the degree of immunosuppression is unclear.

See NIAC's general procedures, immunocompromised patient guidance and measles chapter. For a child taking corticosteroids, use the actual drug, dose, weight, duration and time since stopping treatment to assess immune suppression. In a child on treatment for leukaemia, clinical remission alone does not establish that a live vaccine is safe. The oncology team should advise when and how to catch up.

Explain the decision and obtain consent

Start by explaining the vaccines due and which infections they prevent. Invite questions and check consent. If a parent is worried about egg anaphylaxis, explain why a reaction after eating egg differs from a reaction to the vaccine itself. Review previous vaccine reactions and tell the parent what to expect after the visit.

When asked about autism, explain that research has found no increased autism risk after MMR vaccination. A Danish nationwide cohort study followed over 650,000 children and found no increased risk, including in groups with higher baseline autism risk. Offer to discuss the specific worry and agree a follow-up plan if the parent needs time. Record the decision, the vaccines given and the next visit or catch-up appointment.

Test Your Knowledge

A mother brings her healthy 2-month-old infant to the GP surgery for his first primary childhood immunisations. The doctor administers the 6-in-1 vaccine, Pneumococcal Conjugate Vaccine (PCV), Meningococcal B (MenB) vaccine, and oral Rotavirus vaccine. What specific guidance should the doctor provide regarding post-vaccination antipyretic administration?

A

Administer a single dose of ibuprofen immediately following the injection and repeat every 8 hours as needed

B

Administer three prophylactic doses of oral liquid paracetamol: the first dose at vaccination, the second dose 4 to 6 hours later, and the third dose 4 to 6 hours after that

C

Withhold all antipyretics for at least 24 hours because any antipyretic administration permanently blunts the infant's antibody response

D

Administer prophylactic paracetamol only if the infant's measured temperature exceeds 39.0°C on a digital thermometer

Test Your Knowledge

A 12-month-old boy born after 1 October 2024 is due for MMR, MenB and varicella. He previously had confirmed anaphylaxis after eating egg. He has no history of a reaction to a vaccine or its constituents. How should the GP proceed with MMR?

A

Permanently exempt the child from the MMR vaccine because egg anaphylaxis is an absolute contraindication to all live vaccines

B

Refer the child to a tertiary paediatric immunology centre for split-dose desensitisation and skin testing prior to MMR vaccination

C

Defer the MMR vaccine until 5 years of age when immune tolerance to egg proteins is typically established

D

Give MMR at the routine visit using usual vaccination precautions.

Test Your Knowledge

A 13-month-old girl born after 1 October 2024 is receiving active immunosuppressive chemotherapy for acute lymphoblastic leukaemia. Her oncology team deferred the MMR and varicella vaccines that were due at 12 months. Why should the GP continue to withhold them during treatment?

A

MMR and varicella contain live attenuated viruses that can cause severe vaccine-strain infection in a significantly immunosuppressed patient.

B

Chemotherapy causes non-specific hypergammaglobulinaemia that neutralises the vaccine antigens before they can induce an immune response

C

The MMR vaccine induces severe autoimmune haemolysis when co-administered with antimetabolite medications like methotrexate

D

Children with leukaemia have pre-existing innate immunity against measles and varicella and do not require vaccination

Test Your Knowledge

A healthy 13-month-old boy born in November 2024 attends his GP surgery for routine primary immunisations. He previously received all scheduled vaccines at 2, 4, 6, and 12 months, including his first Varicella dose at 12 months and no MenC vaccine at 6 months. Which combination of vaccines should be administered at this 13-month visit according to current HSE and NIAC guidelines?

A

Hib/MenC combined vaccine and PCV (3rd/booster dose) only

B

MenB (4th dose), Hib/MenC combined vaccine, and 4-in-1 (DTaP-IPV)

C

6-in-1 (4th dose), MenC, and PCV (3rd/booster dose)

D

MMR (2nd dose), Varicella (2nd dose), and PCV (3rd/booster dose)

Sections you finish are checked off in the contents.